Journal of Medicinal Chemistry · 2006 · 47 citations · 19 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationAntiretroviral TherapyAntiviral TherapyEnzyme InhibitionEnzyme-substrate RecognitionLigand-based DesignAntiviral Drug DesignAntiviral Structure-activity RelationshipsAntiviral TherapeuticsEnzyme Inhibitor DiscoveryPalladium-catalyzed Cross-couplingProtease InhibitorsViral Proteases
Two series of P1'-extended HIV-1 protease inhibitors comprising a tertiary alcohol in the transition-state mimic exhibiting Ki values ranging from 2.1 to 93 nM have been synthesized. Microwave-accelerated palladium-catalyzed cross-couplings were utilized to rapidly optimize the P1' side chain. High cellular antiviral potencies were encountered when the P1' benzyl group was elongated with a 3- or 4-pyridyl substituent (EC50 = 0.18-0.22 microM). X-ray crystallographic data were obtained for three inhibitors cocrystallized with the enzyme.
19
Changing patterns of mortality across Europe in patients infected with HIV-1
Amanda Mocroft, Stefano Vella, Antonio Chiesi et al. · The Lancet · 1998 · 1.3K citations